Insights
Access our latest insights & resources
Sector: Healthcare
Life Science Tools and Services Q4 Earnings Preview: Low Visibility for Most in the Near Term
Research, Fundamental
LSTS companies in the US will report their Q4 2023 earnings...
Read more
Drug Distributors: Prescription Volumes, New Therapies Powering Higher Stock Prices
Research, Fundamental
Drug distributors MCK, COR, and CAH have been performing significantly...
Read more
European Health Care Equipment and Services: A Mixed Bag
Research, Fundamental
CFRA sees a mixture of tailwinds and headwinds for the European Health Care Equipment and Services sector...
Read moreLife Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023
Research, Video, Fundamental
During Q2, several companies operating in the Life Science Tools and Services (LSTS) industry...
Read more
MedTech: Near-term Threat of GLP-1 Agonists is Overblown
Research, Fundamental
The market is concerned weight loss drugs (GLP-1 agonists) will...
Read moreLife Science Tools and Services: Time to Be Selective Amid a Challenging H2 2023
Research, Fundamental
Several Life Science Tools and Services (LSTS) companies had a tough Q2, negatively...
Read more
Implications of the Medicare Price Negotiations Announcement for BMY and JNJ
Research, Fundamental
The Centers for Medicare & Medicaid Services (CMS) released a list...
Read more
August PDUFA Calendar
Research, Policy
August will be a busy month for FDA approvals with unofficially 22 applications...
Read moreShockwave (SWAV): No Higher Rates For Now
Research, Policy
In omitting any narrative discussion of Shockwave’s (SWAV) coronary lithotripsy device..
Read moreFDA Action on Aspartame Unlikely
Research, Policy
Recent reports that the World Health Organization (WHO) will reclassify aspartame...
Read more